Jan 2020

ANTG RECEIVES LICENCE TO EXPORT MEDICINAL CANNABIS FLOWER

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

The export of our first commercial crop into the EU provides a significant opportunity for us to scale up our operations and allows us to gather learnings that can support the Australian market. ANTG’s priority remains to provide superior quality medicinal cannabis for local patients in Australia. We continue to invest in research and development to find new applications for medicinal cannabis use and have submissions with regulators to cultivate and distribute medicinal cannabis for patients in Australia.

We have successfully passed three consecutive TGO93 and TGO100 tests on our medicinal cannabis products since our first commercial harvest at the end of 2019.

READ MORE >

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >